Timbang, Romy D.

HRN: 26-30-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2024
CEFTRIAXONE 1G (VIAL)
11/30/2024
12/07/2024
IV
1g
Every 12 Hours
DM Foot, Right
Waiting Final Action 
11/30/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/30/2024
12/07/2024
IV
600mg
Every 12 Hours
DM Foot, Right
Waiting Final Action 
12/01/2024
CEFTAZIDIME 1GM (VIAL)
12/01/2024
12/07/2024
IV
2g
Q8
DM FOOT
Waiting Final Action 
12/05/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
12/05/2024
12/05/2024
TOPICAL
1%
Once
DM FOOT
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: